LABORATORY PARAMETERS IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA DEPENDING ON THE PRESENCE OF CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE

This study investigates the laboratory parameters in patients with chronic cerebral ischemia (CCI) in relation to the presence of concomitant chronic obstructive pulmonary disease (COPD). CCI is characterized by a progressive reduction in cerebral blood flow, while COPD can exacerbate hypoxia, potentially worsening brain ischemia. The research evaluates blood biomarkers, including inflammatory markers and oxygenation indices, to determine the impact of COPD on CCI patients. Results suggest that patients with both CCI and COPD present with more severe inflammatory responses and lower oxygenation levels, which may influence the progression of cerebral ischemia and overall prognosis.